From Diligence to Post-Closing: What’s Shifting in 2026 Health Care Transactions
Private Equity Investment in Health Care
Healthcare Trend Report: A Review of the Pharmacy and Drug Supply Chain Sectors
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — Payments Pros – The Payments Law Podcast
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — The Consumer Finance Podcast
AGG Talks: Government Insight for Life Sciences Leaders | Patient Assistance Programs and the False Claims Act: Enforcement Trends and Compliance Risks for Life Sciences Companies
Health-e Law Episode 19: From AI to OBBBA: Healthcare Law Insights from the 2025 WHLC Leadership Summit with Amy Dilcher and Chi Huynh, WHLC Co-Chairs
Video Overview: Healthcare Trend Report - A Review of the Pharmacy and Drug Supply Chain Sectors
Concierge Practices: Understanding the Model and Its Unique Challenges
Beyond the Bylaws: The Medical Staff Show - How to Build Compliant and Effective Peer Review Processes into Your Bylaws, Part 2
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 264: 2026 Healthcare Industry Trends & Challenges with Lauren DeMoss and Matthew Roberts
Investors Prepare to Navigate FDA Crosswinds Ahead of the J.P. Morgan Healthcare Conference
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 263: Building NC's Innovation Ecosystem with Andrea Conner of First Flight Venture Center
Hospice Insights Podcast - Hospital to Hospice: Managing Referrals and Relationships
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 262: Breaking the “Undruggable” Barrier with Marcel Frenkel of Ten63 Therapeutics
12 Days of Regulatory Insights: Day 7 – Tobacco and Nicotine Regulatory Roundup — Regulatory Oversight Podcast
Navigating FDA's 2025 AI Guidance: Risk-Based Framework, Public Comments, and Generative Models - The Good Bot Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 261: Transforming Lives with Advanced BioMaterials with Dr. Juliana Blum of BioAesthetics
The Down-Low on Data for Value-Based Enterprises and Their Participating Providers – Diagnosing Health Care Video Podcast
The Corner Series Podcast: Scaling Medical Aesthetics
The much-anticipated appellate showdown regarding the constitutionality of the whistleblower (or qui tam) provision of the federal False Claims Act (FCA) took place before a three-judge panel of the Eleventh Circuit Court of...more
Healthcare fraud is a major issue. According to federal government estimates, it costs taxpayers in the realm of $100 billion every year. While the U.S. Department of Justice (DOJ) and U.S. Department of Health and Human...more
Hosts Heather and Lauren sit down with Patrick McCarthy, CEO of Validcare, to discuss how technology is reshaping the future of clinical research. Patrick shares how Validcare is re-engineering the traditional CRO model,...more
Internal investigations are an important component of an effective legal and compliance program within health care organizations. These investigations may arise from many varied situations ranging from patient complaints,...more
On December 31, 2025, the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) announced that that they were issuing a Fourth Temporary Extension of the COVID-19 Telemedicine...more
State attorneys general (AGs) are among the most active and influential regulators in the U.S., using broad statutory authority, political visibility, and growing technical knowledge to shape policy and enforcement across...more
To help you stay on top of the latest news, our AI practice group has compiled a roundup of the developments we are following....more
The Hatch-Waxman Act has always represented a delicate balance between the interests of innovator and generic drugmakers: innovators seek to maintain exclusivity as broadly and long as possible, generics seek to come to...more
On Friday, the Supreme Court granted certiorari in Hikma Pharmaceuticals v. Amarin Pharma, ending an almost three-year lull in patent cases at the Court. The case presents two related questions, one framed specifically in the...more
Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs...more
On December 15, 2025, the US Food and Drug Administration (FDA) issued a press release announcing that FDA eliminated a major barrier to the use of real-world evidence (RWE) in medical device regulatory submissions. ...more
Each week while Congress is in session, our Policy team delivers a key update to highlight a topical benefits, health, or retirement news item from the Hill, such as a newly introduced bill, a summary of a committee hearing,...more
Earlier this week, the Departments of Health and Human Services (HHS) and Agriculture (USDA) published the 2025–2030 Dietary Guidelines, with HHS as the primary author....more
On January 15th, 2026, the Decree amending, adding, and repealing various provisions of the General Health Law (“Amendment”) was published in the Federal Official Gazette. While the prohibition of vaping devices has drawn...more
On January 16, 2026, the U.S. Department of Justice (DOJ) released its annual False Claims Act (FCA) enforcement statistics, announcing that FCA settlements and judgments exceeded $6.8 billion in the fiscal year (FY) ending...more
On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent dispute that could reshape the landscape of generic drug competition and patent enforcement....more
The United States Food and Drug Administration (FDA) issued revisions this month to its guidance documents "Clinical Decision Support Software" (CDS Guidance) and "General Wellness: Policy for Low Risk Devices" (General...more
The Center for Medicare and Medicaid Innovation (CMMI) recently released information about three new models aimed at testing alternative calculations for manufacturer rebates, to ensure net drug prices are closer to those in...more
On January 7, 2025, the US Departments of Health and Human Services and Agriculture released the long-awaited 2025–2030 Dietary Guidelines for Americans (DGAs or Guidelines), marking “the most significant reset of federal...more
On December 1, 2025, the First Circuit Court of Appeals delivered a decision that should bring welcome relief to clinical laboratories facing False Claims Act (FCA) allegations. In United States ex rel. OMNI Healthcare,...more
On the heels of the 44th Annual J.P. Morgan Health Care Conference, Troutman Pepper Locke attorneys Joe Kadlec and Emma Trivax discuss how AI, shifting regulatory scrutiny, and evolving investor oversight are reshaping health...more
Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 (see The Focus of Federal Proposals on Pharmacy Benefit Management – 118th...more
Americans are beginning the new year with a new food pyramid. Whole proteins, fruits, and vegetables are at the top, while processed foods—especially ultraprocessed foods—are out of favor. But this movement began long before...more
As part of its calendar year 2026 Medicare Physician Fee Schedule, the Centers for Medicare and Medicaid Services (“CMS”) made permanent a major change to its physician direct supervision rules. Effective January 1, 2026, for...more
El 15 de enero de 2026 se publicó en el Diario Oficial de la Federación el Decreto por el que se reforman, adicionan y derogan diversas disposiciones de la Ley General de SaludAunque se ha destacado la prohibición de los...more